BOSTON (April 22, 2021)—Current Health—a enterprise remote care management platform—today announced it has raised $43 million in Series B financing. The round was led by Northpond Ventures, with additional financing from LRVHealth, OSF HealthCare, Section 32, Elements Health Ventures and existing investors. Andrea Jackson, Director at Northpond Ventures, and Tripp Peake, General Partner at LRVHealth, will join Current Health’s Board of Directors.


PETAH TIKVA, Israel (January 20, 2021)—Biobeat, a global provider of continuous remote patient monitoring solutions for the health care continuum, has launched a new home-based remote patient monitoring kit. The solution allows health care providers to remotely monitor patients' vital signs and receive updates and deterioration alerts, helping to alleviate hospital overload, reduce costs and improve patient care.
 

MINNEAPOLIS, (January 14, 2021)—Nonin Medical announced the appointment of four new members to the company's board of directors. Each of the new directors brings unique industry experience and passion for innovation in the medtech and healthcare sectors. Together, they will provide Nonin with strategic guidance and support the company's continued growth. The new board members are:
 


CHICAGO (November 18, 2020)—Blipcare, the company that developed the world's first Wi-Fi blood pressure monitor, announced availability of its new cellular blood pressure monitor, the Blip BP800. The Blip BP800 is specifically designed to serve patients who need Remote Patient Monitoring (RPM). It requires neither setup nor cables to plug in. The monitor is the only product of its kind on the market that supports multiple users - and even guest users.

ST. LOUIS (Sept. 10, 2020)—CareSignal, offering Deviceless Remote Patient Monitoring (RPM) validated in more than 10 peer-reviewed journal publications to deliver industry-leading clinical and financial returns, has supported tens of thousands of individual patients with heart failure, COPD, diabetes, depression and dozens of other conditions for a combined duration of more than 20,000 patients/year.